Precigen, Inc. (PGEN)
7.11
-0.03
(-0.42%)
USD |
NASDAQ |
Sep 04, 16:00
7.11
0.00 (0.00%)
After-Hours: 20:00
Precigen Net Income (Annual) : -250.64M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -250.64M |
| December 31, 2024 | -126.24M |
| December 31, 2023 | -95.90M |
| December 31, 2022 | -79.78M |
| December 31, 2021 | -110.81M |
| December 31, 2020 | -103.77M |
| December 31, 2019 | -170.33M |
| December 31, 2018 | -414.32M |
| Date | Value |
|---|---|
| December 31, 2017 | -126.82M |
| December 31, 2016 | -190.27M |
| December 31, 2015 | -87.99M |
| December 31, 2014 | -85.62M |
| December 31, 2013 | -59.30M |
| December 31, 2012 | -81.87M |
| December 31, 2011 | -85.28M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Anika Therapeutics, Inc. | -9.979M |
| Geron Corp. | -83.50M |
| Neurocrine Biosciences, Inc. | 478.60M |
| Aldeyra Therapeutics, Inc. | -33.85M |
| Elicio Therapeutics, Inc. | -39.57M |